Working… Menu

The Development and Evaluation of an "E-Visit" Program for the Management of Acne

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00417456
Recruitment Status : Completed
First Posted : January 1, 2007
Last Update Posted : March 16, 2012
Information provided by (Responsible Party):
Joseph C. Kvedar, Massachusetts General Hospital

Brief Summary:

The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:

  1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
  2. That providers and patients will be satisfied with this model.
  3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.
  4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.

Condition or disease Intervention/treatment Phase
Acne Vulgaris Other: Evisit Other: Office visit Not Applicable

Detailed Description:

Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.

Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.

Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:

Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.

Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.

At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 151 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Development and Evaluation of an "E-Visit" Program for the Management of Acne
Study Start Date : October 2005
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne

Arm Intervention/treatment
Active Comparator: 1
Office Visits
Other: Office visit
Conventional office-based care

Experimental: 2
Other: Evisit
Asynchronous,remote care delivery via a secure web platform
Other Name: RelayHealth platform

Primary Outcome Measures :
  1. Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Subject satisfaction [ Time Frame: 6 months ]
  2. Physician satisfaction [ Time Frame: 6 months ]
  3. Timing of visits [ Time Frame: ongoing ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   12 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 12 or older
  • Diagnosis of mild to severe facial acne
  • Access to a credit card
  • Access to an Internet connection and a computer
  • Ability to image self
  • MA Blue Cross/ Blue Shield Coverage

Exclusion Criteria:

  • Non-English speaking individuals
  • Patients taking Accutane for their acne
  • Impaired Physical ability to image self
  • Impaired Cognitive ability

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00417456

Layout table for location information
United States, Massachusetts
MGH Dermatology Associates
Boston, Massachusetts, United States, 02114
Brigham and Women's Hospital Department of Dermatology
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
Massachusetts General Hospital
Layout table for investigator information
Principal Investigator: Joseph C. Kvedar, M.D. Massachusetts General Hospital
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Joseph C. Kvedar, Director, Center for Connected Health, Massachusetts General Hospital Identifier: NCT00417456    
Other Study ID Numbers: 2005-P-000289
First Posted: January 1, 2007    Key Record Dates
Last Update Posted: March 16, 2012
Last Verified: March 2012
Keywords provided by Joseph C. Kvedar, Massachusetts General Hospital:
Additional relevant MeSH terms:
Layout table for MeSH terms
Acne Vulgaris
Acneiform Eruptions
Skin Diseases
Sebaceous Gland Diseases